Literature DB >> 6428507

Adjuvant questions.

D Brinkley.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6428507      PMCID: PMC1441548          DOI: 10.1136/bmj.288.6432.1709

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.

Authors:  J Lacour; F Lacour; A Spira; M Michelson; J Y Petit; G Delage; D Sarrazin; G Contesso; J Viguier
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-25

2.  Controlled trial of adjuvant chemotherapy with melphalan for breast cancer.

Authors:  R D Rubens; J L Hayward; R K Knight; R D Bulbrook; I S Fentiman; M Chaudary; A Howell; H Bush; D Crowther; R A Sellwood; W D George; J M Howat
Journal:  Lancet       Date:  1983-04-16       Impact factor: 79.321

3.  Detection of micrometastases in patients with primary breast cancer.

Authors:  W H Redding; R C Coombes; P Monaghan; H M Clink; S F Imrie; D P Dearnaley; M G Ormerod; J P Sloane; J C Gazet; T J Powles
Journal:  Lancet       Date:  1983-12-03       Impact factor: 79.321

4.  Multimodal treatment in operable breast cancer: five-year results of the CMF programme.

Authors:  A Rossi; G Bonadonna; P Valagussa; U Veronesi
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

5.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.

Authors:  B Fisher; M Bauer; D L Wickerham; C K Redmond; E R Fisher; A B Cruz; R Foster; B Gardner; H Lerner; R Margolese
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

6.  Long-term survival of patients with breast cancer: a study of the curability of the disease.

Authors:  A O Langlands; S J Pocock; G R Kerr; S M Gore
Journal:  Br Med J       Date:  1979-11-17

7.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.